Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Eli Lilly stock hits all-time high: What’s been driving the ...

   www.aol.com/finance/eli-lilly-stock-hits-time...

   June 12, 2024 at 9:06 AM. Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive ...

3. Eli Lilly stock jumps on GLP-1 sales, end of manufacturing ...

   www.aol.com/finance/eli-lilly-stock-jumps-glp...

   Eli Lilly reported significantly better-than-expected earnings Thursday, with revenue coming in 13% higher than Wall Street estimates of $11.3 billion for the second quarter.That's a 36% jump in ...

4. Mounjaro Maker Eli Lilly's Bumper Q2 Earnings Exceeds ... - AOL

   www.aol.com/mounjaro-maker-eli-lillys-bumper...

   On Thursday, Eli Lilly And Co (NYSE:LLY) reported second-quarter revenue of $11.3 billion, up 36% year over year, easily surpassing the consensus of $9.95 billion. The increase was driven by a 27% ...

5. Why Eli Lilly Stock's Big Jump Last Week Could Be Just the ...

   www.aol.com/finance/why-eli-lilly-stocks-big...

   August 13, 2024 at 5:50 AM. For a while, it seemed the streak was over for Eli Lilly (NYSE: LLY). Shares of the big drugmaker skyrocketed nearly 160% between early 2023 and mid-July of this year ...

6. Eli Lilly Stock Analysis: Buy, Hold, or Sell?

   www.aol.com/finance/eli-lilly-stock-analysis-buy...

   Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn ...

7. Weight-loss drug powers Lilly results, 2024 forecast raised ...

   www.aol.com/news/eli-lilly-raises-annual-profit...

   With shares up about 8% at midday to $831 after earlier climbing as high as $877.78, the Indianapolis-based drugmaker was on track to add nearly $55 billion to its market value if stock gains hold.

8. Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep ...

   www.aol.com/finance/eli-lily-ceo-think-bet...

   After a record year in 2023, Eli Lilly — fueled by the success of its GLP-1 drug, tirzepatide, used in Mounjaro for diabetes and Zepbound for obesity — isn't slowing down in the space, knowing ...

9. Eli Lilly’s CFO explains why the company’s newest ... - AOL

   www.aol.com/finance/eli-lilly-cfo-explains-why...

   Lilly (No. 142 on the Fortune 500), the Indianapolis-based pharmaceutical company, announced on Nov. 8 that Zepbound, a weight-loss drug, was approved by the U.S. Food and Drug Administration. The ...